Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00268216
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
6228
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
Salmeterol 50mcg/ Fluticasone Propionate 500mcg
Sponsor
GlaxoSmithKline